Navigation Links
Lumenis Ltd. Announces Senior Leadership Appointments Strengthening the Company's Strategic Businesses
Date:10/15/2007

Dale Koop will take up position of Sr. Vice President and General Manager

of the Lumenis' Aesthetic Business on October 21st 2007.

YOKNEAM, Israel, Oct. 15 /PRNewswire-FirstCall/ -- Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, ophthalmic, dental and veterinary applications, announced the appointment of Dale Koop as Senior Vice President and General Manager of the Lumenis Aesthetic Business Unit effective October 21, 2007.

"After an extensive search for the right person to head our Aesthetic Business, we determined Dale Koop to be an outstanding candidate. He brings to Lumenis over 20 years of management experience in the medical aesthetic laser sector," said Mr. Dov Ofer, CEO of Lumenis.

Prior to joining Lumenis, Dale Koop held the role of General Manager at Sciton. His previous experience includes roles as Vice President of Research and Development at the Industrial Laser Division of Siemens, Business Development Manager at Coherent Medical where he started Coherent's Aesthetic Business Unit and their market for laser skin resurfacing, CEO of Lightwave Electronics, and President at CoolTouch Corp where he launched their business for non-ablative skin rejuvenation. Mr. Koop holds a PhD in Physics from Caltech, and BS degrees in both Biology and Physics.

This nomination is the latest in a series of senior appointments at Lumenis, and reconfirms the company's commitment to growing its business with a world class executive management team to lead its efforts. Dale Koop joins Lloyd Diamond, Senior Vice President & General Manager of the Surgical Business Unit, and Jake Vander Zanden, Senior Vice President & General Manager of the Ophthalmic Business Unit, who were appointed earlier in the year, to execute the company's growth and leadership positions in the markets the company serves.

"We have an exceptional and experienced management tea
'/>"/>

SOURCE Lumenis Ltd.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Increasing exercise, water and fruit consumption leads to success, study finds , , FRIDAY, Dec. 4 (HealthDay News) -- Increased exercise, reduced soda consumption and self-weighing are among
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Teens Lose More Weight Using Healthy Strategies 2
...enter Institute (JCVI) announced today that they h... from the National Institute of Allergy and Infect...utes of Health, as one of their Genomic Sequencing...nable JCVI to continue to expand its decades-long ...
...th Month and groups across the country and around ...n celebration of this awareness period. The purpo...ess of preventable health problems and encourage e...Father,s Day, a special awareness period recognize...
...a global leader in high-performance polymer extrus... International Sales. Gifford is experienced in ge...s development within the manufacturing, financial,... success record in terms of the sale of complex an...
...ability equates to success, , , FRIDAY, Ma...ive pitchers the extra edge they need to rule the ...lvic control of 24 pitchers, ages 18 to 26, in the...s wore a device that measured pelvic stability by ...
...s Expanding Ocular Pharmaceuticals Portfolio and O...cular Bacterial Pathogens(1) - , , , MADISON, N....ye health, today announced that the U.S. Food and ...eferred to as "pink eye." Besivance(TM) is a ne...
...vides Better Diagnosis and Treatment for Patients ...Kenneth L. Reed, M.D. performed the first revoluti...mpression (D.N.D.) procedure to treat acute and ...th area. The surgery is also currently being perfo...
Other Medicine News:Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 2Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 3Health News:Join Men's Health Network in Celebration of Men's Health Month 2Health News:Join Men's Health Network in Celebration of Men's Health Month 3Health News:Gifford Named Zeus Director of International Sales 2Health News:Pitching Prowess May Start With the Pelvis 2Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 2Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 3Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 4Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 5Health News:Kenneth L. Reed, M.D. Performs First State of the Art AccuraScope(TM) Procedure in Dallas 2
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 62068 1Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 62068 2Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 62068 3Bionorica Offers Expert Resources Health Tips for Natural Moms 62064 1Bionorica Offers Expert Resources Health Tips for Natural Moms 62064 2Two Major Universities Join Nations Leading Postgrad Bio Job Board 14970 1Two Major Universities Join Nations Leading Postgrad Bio Job Board 14970 2
... Pharmasset, Inc.,(Nasdaq: VRUS ) announces that... clevudine for the treatment of chronic hepatitis ...sults of R7128 for the treatment of,chronic hepati...rs in Drug,Development in Viral Hepatitis (HEP-DAR...cember 9 - 13, 2007. The abstract titles and abbre...
... Magazines like Time, Newsweek,and U.S. World and ...,probiotics. Researchers have found compelling evi...t key to digestive and immune health, but Eastern,...f probiotics, found in,fermented foods such as yog...nning to tout probiotic benefits, Russian scientis...
Other Medicine Technology:Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART 2Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART 3Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART 4Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART 5Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART 6Are Muramyl Peptides the Magic Bullet in Probiotics? 2Are Muramyl Peptides the Magic Bullet in Probiotics? 3
New Image Cut-to-Fit Flextend Skin Barrier, Floating Flange
New Image Cut-to-Fit Convex Flextend Skin Barrier, with Tape
CenterPointLock Urostomy Pouch
CenterPointLock Sterile Urostomy Kit
Medicine Products: